Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Boxed warning of HBV risk added to Rituxan, Arezerra
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Opinion: Sex inclusion in basic research drives discovery.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Berlex continues legal challenge to FDA over MS drug.
Merck: Regulatory Update on Cladribine Tablets
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Regulation of prefrontal cortex myelination by the microbiota.
Limit cycle oscillations in standing human posture.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Interferon-β-1b: a review of its use in multiple sclerosis.
Flupirtine

Pages